Xcell Therapeutics Inc. — Investor Relations & Filings
Xcell Therapeutics Inc. is a company specializing in the research, development, and production of advanced cell culture media. Its primary product line, CellCor™, consists of serum-free, chemically defined media designed to provide an optimal environment for cell culture, particularly for mesenchymal stem cells (MSCs). The technology aims to enhance efficiency and yield for researchers and developers in the fields of cell therapy and regenerative medicine. By offering a serum-free alternative, the company provides a more consistent and defined solution compared to traditional media. Xcell Therapeutics is also expanding its services to become a Contract Development and Manufacturing Organization (CDMO) and is exploring applications for its media in the cultured meat sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 증권신고서(지분증권) (2025.11) | 2025-08-18 | Korean | |
| 반기보고서 (2025.06) | 2025-08-14 | Korean | |
| 주요사항보고서(유상증자결정) | 2025-08-14 | Korean | |
| 분기보고서 (2025.03) | 2025-05-15 | Korean | |
| 정기주주총회결과 | 2025-03-28 | Korean | |
| 주식매수선택권부여에관한신고 | 2025-03-28 | Korean |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 7871408 | 증권신고서(지분증권) (2025.11) | 2025-08-18 | Korean | ||
| 7874008 | 반기보고서 (2025.06) | 2025-08-14 | Korean | ||
| 7873468 | 주요사항보고서(유상증자결정) | 2025-08-14 | Korean | ||
| 7900654 | 분기보고서 (2025.03) | 2025-05-15 | Korean | ||
| 7919521 | 정기주주총회결과 | 2025-03-28 | Korean | ||
| 7919118 | 주식매수선택권부여에관한신고 | 2025-03-28 | Korean | ||
| 7926002 | 감사보고서제출 | 2025-03-20 | Korean | ||
| 7925984 | 사업보고서 (2024.12) | 2025-03-20 | Korean | ||
| 7958692 | 주주총회소집결의 | 2025-03-12 | Korean | ||
| 7958690 | 주주총회집중일개최사유신고 | 2025-03-12 | Korean | ||
| 7958527 | 주주총회소집공고 | 2025-03-12 | Korean | ||
| 7958214 | 의결권대리행사권유참고서류 | 2025-03-12 | Korean | ||
| 7985885 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2025-02-07 | Korean | ||
| 7988093 | 기업설명회(IR)개최 | 2025-02-04 | Korean | ||
| 7990118 | 기업설명회(IR)개최 | 2025-01-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Xcell Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16801/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16801 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16801 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16801 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16801}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xcell Therapeutics Inc. (id: 16801)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.